A study of inflammation-based predictors of tumor response to neoadjuvant chemoradiotherapy for locally advanced rectal cancer

Oncology (Switzerland)

Volumn 85, Issue 1, 2013, Pages 27-32

  Krauthamer, Mark ^a   Rouvinov, Keren ^a,b   Ariad, Samuel ^a,b   Man, Sofia ^a,b   Walfish, Shlomo ^a,b   Pinsk, Ilia ^a,b   Sztarker, Ignatio ^b   Charkovsky, Tatiana ^c   Lavrenkov, Konstantin ^a,b  

^a BEN GURION UNIVERSITY OF THE NEGEV   (Israel)

^b BEN GURION UNIVERSITY OF THE NEGEV   (Israel)

^c BARZILAI MEDICAL CENTER   (Israel)

Author keywords

Neoadjuvant chemoradiotherapy; Pretreatment inflammatory response; Rectal cancer

Indexed keywords

FLUOROPYRIMIDINE; FLUOROURACIL; FOLINIC ACID; HEMOGLOBIN; SERUM ALBUMIN;

ADJUVANT CHEMORADIOTHERAPY; ADULT; ADVANCED CANCER; AGED; ARTICLE; BLOOD CELL COUNT; CANCER SURVIVAL; COMPLETE PATHOLOGICAL RESPONSE; FEMALE; HUMAN; HUMAN CELL; INFLAMMATION; LOCALLY ADVANCED RECTAL CANCER; LYMPHOCYTE; MAJOR CLINICAL STUDY; MALE; NEOADJUVANT CHEMORADIOTHERAPY; OVERALL SURVIVAL; PREDICTOR VARIABLE; PRIORITY JOURNAL; RECTUM CANCER; RETROSPECTIVE STUDY; TREATMENT RESPONSE;

EID: 84879485584     PISSN: 00302414     EISSN: 14230232     Source Type: Journal    
DOI: 10.1159/000348385     Document Type: Article

References (35)

1. Jemal A, Bray F, Center MM, et al: Global cancer statistics. CA Cancer J Clin 2011; 61: 69-90.
2. Cammá C, Giunta M, Fiorica F, et al: Preoperative radiotherapy for resectable rectal cancer: a meta-Analysis. JAMA 2000; 284: 1008-1015.
3. Sauer R, Becker H, Hohenberger W, et al: Preoperative versus postoperative chemoradiotherapy for rectal cancer. N Engl J Med 2004; 351: 1731-1740.
4. Gérard JP, Conroy T, Bonnetain F, et al: Preoperative radiotherapy with or without concurrent fluorouracil and leucovorin in T3-4 rectal cancers: results of FFCD 9203. J Clin Oncol 2006; 24: 4620-4625.
5. Bosset JF, Collette L, Calais G, et al: Chemotherapy with preoperative radiotherapy in rectal cancer. N Engl J Med 2006; 355: 1114-1123.
6. Collette L, Bosset JF, den Dulk M, et al: Patients with curative resection of cT3-4 rectal cancer after preoperative radiotherapy or radiochemotherapy: does anybody benefit from adjuvant fluorouracil-based chemotherapy A trial of the European Organisation for Research and Treatment of Cancer Radiation Oncology Group. J Clin Oncol 2007; 25: 4379-4386.
7. Dworak O, Keilholz L, Hoffmann A: Pathological features of rectal cancer after preoperative radiochemotherapy. Int J Colorectal Dis 1997; 12: 19-23.
8. Chan AKP, Wong A, Jenken D, et al: Posttreatment TNM staging is a prognostic indicator of survival and recurrence in tethered or fixed rectal carcinoma after preoperative chemotherapy and radiotherapy. Int J Radiat Oncol Biol Phys 2005; 61: 665-677.
9. Rödel C, Martus P, Papadoupolos T, et al: Prognostic significance of tumor regression after preoperative chemoradiotherapy for rectal cancer. J Clin Oncol 2005; 23: 8688-8696.
10. Wiig JN, Larsen SG, Dueland S, Giercksky KE: Clinical outcome in patients with complete pathologic response (pT0) to preoperative irradiation/chemo-irradiation operated for locally advanced or locally recurrent rectal cancer. J Surg Oncol 2005; 92: 70-75.
11. Stipa F, Chessin DB, Shia J, et al: A pathologic complete response of rectal cancer to preoperative combined-modality therapy results in improved oncological outcome compared with those who achieve no downstaging on the basis of preoperative endorectal ultrasonography. Ann Surg Oncol 2006; 13: 1047-1053.
12. Bujko K, Michalski W, Kepka L, et al: Association between pathologic response in metastatic lymph nodes after preoperative chemoradiotherapy and risk of distant metastases in rectal cancer: an analysis of outcomes in a randomized trial. Int J Radiat Oncol Biol Phys 2007; 67: 369-377.
13. Quah HM, Chou JF, Gonen M, et al: Pathologic stage is most prognostic of disease-free survival in locally advanced rectal cancer patients after preoperative chemoradiation. Cancer 2008; 113: 57-64.
14. Cooper EH, Stone J: Acute phase reactant proteins in cancer. Adv Cancer Res 1979; 30: 1-44.
15. De Mello J, Struthers L, Turner R, et al: Multivariate analyses as aids to diagnosis and assessment of prognosis in gastrointestinal cancer. Br J Cancer 1983; 48: 341-348.
16. Kern KA, Norton JA: Cancer cachexia. J Parenter Enteral Nutr 1988; 12: 286-298.
17. Koea JB, Shaw JH: The effect of tumor bulk on the metabolic response to cancer. Ann Surg 1992; 215: 282-288.
18. McMillan DC, Wotherspoon HA, Fearon KC, et al: A prospective study of tumor recurrence and the acute-phase response after apparently curative colorectal cancer surgery. Am J Surg 1995; 170: 319-322.
19. Crumley ABC, McMillan DC, McKernan M, et al: Evaluation of an inflammation-based prognostic score in patients with inoperable gastro-oesophageal cancer. Br J Cancer 2006; 94: 637-641.
20. Sasaki A, Iwashita Y, Shibata K, et al: Prognostic value of preoperative peripheral blood monocyte count in patients with hepatocellular carcinoma. Surgery 2006; 139: 755-764.
21. Vaupel P, Mayer A, Hockel M: Impact of hemoglobin level on tumour oxygenation: the higher the better Strahlenther Oncol 2006; 182: 63-71.
22. Hoff CM, Hansen HS, Overgaard M, et al: The importance of hemoglobin level and effect of transfusion in HNSCC patients treated with radiotherapy-results from the randomized DAHANCA 5 study. Radiother Oncol 2011; 98: 28-33.
23. Sasaki K, Kawai K, Tsuno NH, et al: Impact of preoperative thrombocytosis on the survival of patients with primary colorectal cancer. World J Surg 2012; 36: 192-200.
24. AJCC Cancer Staging Manual (ed 7). New York, Springer, 2010.
25. Fisher RA: On the interpretation of ? 2 from contingency tables, and the calculation of p. J Royal Stat Soc 1922; 85: 87-94.
26. LaValley MP: Logistic regression. Circulation 2008; 117: 2395-2399.
27. Kaplan E, Meier P: Nonparametric estimation from incomplete observations. J Am Stat Assoc 1958; 53: 457-481.
28. Walsh SR, Cook EJ, Goulder F, et al: Neutrophil-lymphocyte ratio as a prognostic factor in colorectal cancer. J Surg Oncol 2005; 91: 181-184.
29. Sasaki A, Kai S, Endo Y, et al: Prognostic value of preoperative peripheral blood monocyte count in patients with colorectal liver metastasis after liver resection. J Gastrointest Surg 2007; 11: 596-602.
30. Ishizuka M, Nagata H, Takagi K, Kubota K: Influence of inflammation-based prognostic score on mortality of patients undergoing chemotherapy for far advanced or recurrent unresectable colorectal cancer. Ann Surg 2009; 250: 268-272.
31. Ding PR, An X, Zhang RX, Fang YJ, et al: Elevated preoperative neutrophil to lymphocyte ratio predicts risk of recurrence following curative resection for stage IIA colon cancer. Int J Colorectal Dis 2010; 25: 1427-1433.
32. Qiu MZ, Yuan ZY, Luo HY, et al: Impact of pretreatment hematologic profile on survival of colorectal cancer patients. Tumour Biol 2010; 31: 255-260.
33. Chua W, Charles KA, Baracos VE, et al: Neutrophil/lymphocyte ratio predicts chemotherapy outcomes in patients with advanced colorectal cancer. Br J Cancer 2011; 104: 1288-1295.
34. Carruthers R, Tho LM, Brown J, et al: Systemic inflammatory response is a predictor of outcome in patients undergoing preoperative chemoradiation for locally advanced rectal cancer. Colorectal Dis 2012; 14:e701-e707.
35. Kitayama J, Yasuda K, Kawai K, et al: Circulating lymphocyte number has a positive association with tumor response in neoadjuvant chemoradiotherapy for advanced rectal cancer. Radiat Oncol 2010; 5: 47.